Objective. The aim of the present study was to investigate the effect of adipokine NAMPT (nicotinamide phosphoribosyltransferase) silencing on the expression of genes encoding IRS1 (insulin receptor substrate 1) and some other proliferation related proteins in U87 glioma cells for evaluation of the possible significance of this adipokine in intergenic interactions.
The nicotinamide phosphoribosyltransferase (NAMPT) also known as visfatin and PBEF (pre-Bcell colony-enhancing factor) is an insulin-mimetic adipokine with anti-diabetic properties, which is involved in many important biological processes, including metabolism, stress response, insulin resistance, and tumorigenesis (Flehmig et al. 2014; Olszanecka-Glinianowicz et al. 2014; Minchenko et al. 2015a; Carbone et al. 2017; Hesari et al. 2018; Annie et al. 2019; Meram et al. 2019) . This protein catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate yielding to nicotinamide mononucleotide, the rate limiting component in the mammalian NAD biosynthesis pathway. It is secreted form of the adipokine and its circulating levels has been closely correlated with the white adipose tissue accumulation, obesity and contribute to metabolic and vascular complications (Flehmig et al. 2014; Li et al. 2017; Huang et al. 2018) . The secreted form of NAMPT behaves both as a cytokine with immunomodulating properties and an adipokine with antidiabetic properties preferentially independent on its enzymatic activity Tabassum et al. 2018) . Furthermore, there are data indicating that NAMPT-mediated NAD + biosynthesis is indispensable for the adipose tissue plasticity, systemic glucose homeostasis, and the pathological progression of obesity (Nielsen et al. 2018) .
NAMPT is a pleiotropic protein implicated in the pathogenesis of cancer and obesity and its complications, including insulin resistance, diabetes, and aging (Goktas et al. 2013; Shackelford et al. 2013; Zhang et al. 2017; Zhao et al. 2017; Liang et al. 2018; Poljsak 2018; Ohanna et al. 2018) . There are data reporting that inhibition of NAMPT by specific inhibitors decreases cancer growth, induces apoptosis, suppresses cell growth, and enhances the susceptibility to oxidative stress and also sensitizes the glioblastoma cells to temozolomide (Abu Aboud et al. 2016; Feng et al. 2016; Alaee et al. 2017; Xu et al. 2017; Tabassum et al. 2018 ). It has also been shown that down-regulation of NAMPT expression by miR-206 reduces survival of the breast cancer cells that NAMPT expression is up-regulated in pediatric gliomas and that its overexpression induces glioma and other cancers growth (Minchenko et al. 2015a; Lucena-Cacace et al. 2017; Zhao et al. 2017; Hesari et al. 2018) . Moreover, NAMPT can promote hepatocellular carcinoma cell migration through the up-regulation of miR-21 (Liang et al. 2018) .
NAMPT is involved in basic key cellular functions such as transcription, translation, cell signaling, and fundamental metabolism Cheleschi et al. 2018; Liang et al. 2018; Nielsen et al. 2018; Shi et al. 2018 ). However, the underlying molecular mechanisms of NAMPT in physiological and pathological processes are not fully understood. The aim of the present study was to investigate the effect of adipokine NAMPT (nicotinamide phosphoribosyltransferase) silencing on the expression of genes encoding insulin receptor substrate 1 and some other proliferation related proteins in U87 glioma cells for revealing the possible significance of this adipokine in the intergenic interactions. Among others, insulin-like growth factor binding protein 3 (IGFBP3), hexokinase 2 (HK2), period circadian regulator 2 (PER2), clusterin (CLU), BCL2/adenovirus E1B 19 kDa interacting protein 3 (BNIP3), tumor protein D52 (TPD52), growth arrest and DNA-damage-inducible, alpha (GADD45A), and marker of proliferation Ki-67 (MKI67) have been studied. These polyfunctional proteins play an important role in the regulation of metabolism, cell proliferation, surviving and apoptosis and biological clock (Fan et al. 2018; Liu et al. 2018; Qu et al. 2018; Xiong et al. 2018; Xu et al. 2018; Zhou et al. 2018; Chen et al. 2014 Chen et al. , 2019 Niu et al. 2019; Li et al. 2019; Wu et al. 2019 ).
In the present study, we provide experimental evidence that the silencing of NAMPT mRNA resulted in the down-regulation of NAMPT protein and the suppression of the glioma cell proliferation and affected the expression of IRS1 gene and many other genes encoding the proliferation related proteins, which may contribute to the control of the glioma cell metabolism and proliferation.
Materials and methods
Cell line and culture conditions. The glioma cell line U87 was obtained from ATCC (USA) and grown in high glucose (4.5 g/l) Dulbecco's modified Eagle's minimum essential medium (DMEM, Gibco, Invitrogen, Carlsbad, CA, USA) supplemented with glutamine (2 mM), 10% fetal bovine serum (FBS, Equitech-Bio, Inc., USA), penicillin (100 units/ml; Gibco) and streptomycin (0.1 mg/ml; Gibco) at 37 °C in incubator with 5% CO 2 .
The silencing of NAMPT mRNA was introduced by NAMPT specific siRNA (PBEF siRNA (h), sc-45843, Santa Cruz Biotechnology, Inc., Dallas, TX, U.S.A.). Control siRNA-A (sc-37007, Santa Cruz Biotechnology, Inc.) was used for transfection of the control glioma cells. The transfection was performed by lipofectamine RNAiMAX for 48 h (Invitrogen, Carlsbad, CA, USA) in accordance with the manufacturer's protocol, with siRNA at a final concentration of 100 nM.
RNA isolation. Total RNA was extracted from the glioma cells using the Trizol reagent according to manufacturer's protocol (Invitrogen). The RNA pellets were washed with 75% ethanol and dissolved in nuclease-free water. For additional purification, the RNA samples were re-precipitated with 95% ethanol and re-dissolved again in nuclease-free water. The RNA concentration and the spectral characteristics were measured using NanoDrop Spectrophotometer ND1000 (PEQLAB, Biotechnologie GmbH).
Reverse transcription and quantitative PCR analysis. The effect of NAMPT silencing on the expression levels of NAMPT, IGFBP3, IRS1, HK2, PER2, CLU, BNIP3, TPD52, GADD45A, and MKI67 mRNAs as well as ACTB (beta-actin) mRNA was measured in control U87 glioma cells and cells with a deficiency of NAMPT, introduced by NAMPT siRNA, by quantitative polymerase chain reaction using SYBRGreen Mix (ABgene, Thermo Fisher Scientific, Epsom, Surrey, UK), and qPCR "Quant-Studio 5 Real-Time PCR System" (Applied Biosystems, USA). Thermo Scientific Verso cDNA Synthesis Kit (Germany) was used for reverse transcription. The polymerase chain reaction was performed in triplicate. The expression of beta-actin mRNA was used as control of analyzed RNA quantity. The pair of primers specific for each of the studied gene was received from Sigma-Aldrich (St. Louis, MO, U.S.A.) and used for quantitative polymerase chain reaction (Table 1) .
Quantitative PCR analysis was performed using a special computer program "Differential expression calculator" and statistical analysis using Excel program and OriginPro 7.5 software as described previously (Minchenko et al. 2015b ). Comparison of two means was performed by the use of two-tailed Student's t-test. p<0.05 was considered significant in all cases. The values of NAMPT, IGFBP3, IRS1, HK2, PER2, CLU, BNIP3, TPD52, GADD45A, and MKI67 gene expressions were normalized to the expression of beta-actin mRNA and represent as percent of control (100%). All values are expressed as mean ± SEM from triplicate measurements performed in 4 independent experiments. The amplified DNA fragments were also analyzed on a 2% agarose gel and that visualized by SYBR* Safe DNA Gel Stain (Life Technologies, Carlsbad, CA, USA).
Western blot analysis. Cell extracts were prepared using buffers A, as previously described (Armstead et al. 1997 ). The proteins were resolved using sodium dodecyl sulfate-polyacrylamide gel (10% acrylamide) electrophoresis and transferred to a polyvinylidene difluoride membrane (Immobilon-P Transfer Membrane; Millipore, Chelmsford, MA, U.S.A.) by a semi-dry blotting system. The excess sites on the membrane were saturated with 5% non-fat dried milk in TPBS (PBS containing 0.1% Tween 20). Western blot analysis was carried out as described previously (Minchenko et al. 2004) . For detection of NAMPT protein, a rabbit anti-Visfatin, PBEF (412-431) IgG 
Results
We analyzed the effect of adipokine NAMPT silencing on the expression of genes encoding IRS1 and some other important polyfunctional proteins in U87 glioma cells.
As shown in Figure 1 , the expression level of NAMPT mRNA and protein in U87 glioma cells, transfected by siRNA NAMPT, was strongly downregulated in comparison with the control glioma cells, transfected by control siRNA, 48 hours after transfection. Furthermore, the silencing of NAMPT had smaller but still statistically significant effect (-24%) on the proliferation rate of these glioma cells as well as on the expression level of the proliferation marker Ki-67 (-25%) in comparison with control glioma cells, transfected by control siRNA ( Figure  2 ). Further, we investigated the effect of NAMPT silencing on the expression of gene encoding the insulin receptor substrate 1, which can interact with insulin receptor and insulin-like growth factor receptors and mediate the control of various cellular processes by insulin as well as insulinlike growth factors, in glioma cells. As shown in Figure 3 , the expression level of IRS1 mRNA was strongly up-regulated (+200%) in glioma cells after silencing the NAMPT in comparison with the cells, transfected by the control siRNA. More significant up-regulation of the expression level has been shown for gene encoding the insulin-like growth factor binding protein 3 (+542%) in glioma cells with suppressed level of adipokine NAMPT in comparison with control cells (Figure 3 ). This polyfunctional protein plays an important role in the regulation of the insulin-like growth factors and has additional functions independent of IGFs.
At the same time, the silencing of NAMPT in glioma cells led to a strong down-regulation in the expression level of genes encoding the surviving protein clusterin (CLU) and BCL2/adenovirus E1B 19 kDa interacting protein 3 (BNIP3): -96% and -82%, correspondingly, in comparison with the control cells ( Figure 4 ). Furthermore, similar but significant less changes in the expression level we received for gene encoding the hexokinase 2 (-18%), in the glioma cells deficient in NAMPT, introduced by NAMPT specific siRNA, in comparison with cells transfected by the control siRNA ( Figure 5 ). Furthermore, as shown in Figurer 5 and Figure 6 , the silencing of NAMPT in the glioma cells does not significantly change the expression level of genes encoding the circadian period regulator 2 (PER2), growth arrest, DNA-damage-inducible alpha protein (GADD45A), and the tumor protein D52 (TPD52), as compared to the control glioma cells. By resuming, the silencing of NAMPT, introduced by NAMPT specific siRNA, leads to variable changes in the expression level of genes encoding very important polyfunctional proteins, which play a key role in the regulation of the cell proliferation, surviving, apoptosis, and metabolism, as well as the biological clock.
Discussion
In this work, we studied the expression of genes encoding the insulin receptor substrate 1, insulinlike growth factor binding protein 3, and several other genes, which have relation to regulation of the cell proliferation, surviving, apoptosis, and metabolism, in relation to the silencing of NAMPT, introduced by NAMPT specific siRNA. It is important for consideration of a possible importance of adipokine NAMPT in the control of glioma growth through intergenic interactions. There are data indicating that the expression of NAMPT gene is up-regulated in gliomas and that overexpression of this adipokine induces glioma and other cancers growth and that the inhibition of NAMPT by specific inhibitors decreases cancer growth, induces apoptosis, suppresses cell growth, and enhances the susceptibility to oxidative stress as well as sensitizes glioblastoma cells to temozolomide (Minchenko et al. 2015a; Abu Aboud et al. 2016; Feng et al. 2016; Alaee et al. 2017; Lucena-Cacace et al. 2017; Xu et al. 2017; Zhao et al. 2017; Hesari et al. 2018) . We have shown that silencing of NAMPT leads to a strong down-regulation of this adipokine mRNA expression with a subsequent suppression of NAMPT protein level in the glioma cells as well as the suppression of the cell proliferation (Figure 7) . Similar results have been received by Bong et al. (2016) using RPMI 8226 cells. They have shown that the silencing of NAMPT decreases the protein level of this adipokine and suppresses the proliferation of these cells. These data agree well with our results concerning the down-regulation of the expression level of Ki-67 marker of proliferation in U87 glioma cells. Accordingly, our data indicating that the silencing of adipokine NAMPT mRNA leads to a significant reduction of this adipokine protein and subsequent suppression of the glioma cell proliferation agree well with the prooncogenic function of NAMPT, which is implicated in cancer development Figure 6 . Effect of NAMPT silencing on the expression of growth arrest and DNA-damage-inducible alpha (GAD-D45A) and tumor protein D52 (TPD52) mRNAs in glioma cells treated by siRNA NAMPT and control siRNA. The values of these mRNA expressions were normalized to the expression of beta-actin mRNA, expressed as mean ± SEM and represented as a percent of control (100%); n=4. and progression (Minchenko et al. 2015a; Feng et al. 2016; Alaee et al. 2017; Lucena-Cacace et al. 2017; Xu et al. 2017; Zhao et al. 2017; Hesari et al. 2018; Meram et al. 2019) .
Previously it has been shown that inhibition of the nicotinamide phosphoribosyltransferase decreases the cell growth and enhances the susceptibility to oxidative stress through down-regulation 325 proteins in the FK866-treated 293T cells as well as through reduction of mitochondrial ribosomal proteins and subsequent mitochondrial dysfunction . There are also data indicating that NAMPT inhibitor APO866 increased the expression of aggrecan and collagen II inhibited by IL-1beta and the autophagic markers, LC3 and beclin-1 (Shi et al. 2018) . These data clearly demonstrate that NAMPT is a pleiotropic protein implicated in the regulation of variable processes as well as in pathogenesis of cancer, diabetes, obesity, and other diseases because it is involved in the basic key cellular functions such as transcription, translation, cell signaling, and metabolism ) and agree well with our results regarding the dependence of the expression of different genes on the level of NAMPT, which reflects fairly close relationships between different genes in the regulation of their functional activity.
As shown in Figure 7 , inducible effect of NAMPT silencing on the expression of gene encoding insulin receptor substrate 1, which can interact with insulin receptor and insulin-like growth factor receptors and mediate the control of various cellular processes by insulin as well as insulin-like growth factors Sun et al. 2019; Wu et al. 2019) , is not correlated well with suppression of cell proliferation of glioma cells, but a strong up-regulation of IGFBP3, which has anti-proliferative properties (Yan et al. 2017; Fan et al. 2018; Zhou et al. 2018; Tu et al. 2019) , and possibly contributes to the anti-proliferative effect of NAMPT silencing. IGFBP3 is a pleiotropic protein, which plays an important role in the regulation of the insulin-like growth factors and has additional functions independent on IGFs (Ingermann et al. 2010; Nedic et al. 2013; Canel et al. 2017; Wang et al. 2017) . We showed that the silencing of NAMPT adipokine leads to down-regulation of the expression of HK2 and CLU genes in glioma cells (Figure 7) . These data agree well with the pro-oncogenic properties of proteins encoded by these genes Chen et al. 2014 Chen et al. , 2019 Yoo et al. 2019) . Actually, there are data indicating that overexpression of HK2 promotes the proliferation and survival of the laryngeal squamous cell carcinoma and that long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in the gallbladder cancer (Chen et 2014, 2019) . Moreover, clusterin promotes growth of the renal carcinoma cell by an upregulation of S100A4 gene expression . At the same time, we showed that the expression of BNIP3 gene is also down-regulated, but BNIP3 has anti-proliferate properties. It is a pleiotropic protein, which plays an important role in the apoptosis and cell proliferation and is down-regulated in tumors (Singh et al. 2018; Shao et al. 2019 ). There are also data available that low BNIP3 expression is associated with the breast tumor progression, because RNA N6-methyladenosine demethylase FTO promotes this tumor progression through inhibiting BNIP3 (Niu et al. 2019 ).
The proteins encoding by PER2, GADD45A, and TPD52 genes are also involved in the cancer cell proliferation and tumor growth and are dysregulated in cancer cells (Wang et al. 2016; Xiang et al. 2018; Xiong et al. 2018; Zhang et al. 2018; Hu et al. 2019; Rahman et al. 2019) . At the same time, the expression of these genes was resistant to the silencing of adipokine NAMPT in the glioma cells. It is possible that PER2, GADD45A, and TPD52 genes are not included in the gene network associated with the adipokine NAMPT and the silencing of this adipokine did not change their expression profile.
This study provides unique insights into the molecular mechanisms regulating the expression of genes encoding IRS1, IGFBP3, HK2, PER2, CLU, BNIP3, TPD52, GADD45A, and MKI67 proteins in glioma cells in response to silencing of adipokine NAMPT and their correlation with reduced cell proliferation, attesting to the fact that this adipokine is a necessary component of malignant tumor growth and cell survival. It is possible that there is functional gene network and that knockdown one gene disruptions genome stability and leads to numerous changes in gene expression directly or indirectly initiated by the excluded gene, in particular NAMPT. However, the detailed molecular mechanisms of this regulation have not been yet clearly defined and warrant further investigation.
